Highly Aggressive Lymphomas in Adults

Hematology/Oncology Clinics of North America

Volumn 22, Issue 5, 2008, Pages 965-978

  Sweetenham, John W ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Burkitt; Burkitt like; Lymphoblastic

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; NELARABINE; PREDNISONE; RITUXIMAB; T LYMPHOCYTE ANTIGEN; TRANSCRIPTION FACTOR; VINCRISTINE; VINDESINE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; BONE MARROW; BRAIN RADIATION; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORPHOLOGY; CANCER STAGING; CANCER SURGERY; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM PROPHYLAXIS; CEREBROSPINAL FLUID; CHILDHOOD CANCER; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CRANIAL NEUROPATHY; CYTOGENETICS; DIGESTIVE SYSTEM PERFORATION; DISEASE FREE SURVIVAL; DRUG MEGADOSE; ENDEMIC DISEASE; EPSTEIN BARR VIRUS; FACE CANCER; FACIAL BONE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL OBSTRUCTION; GENE; GENE EXPRESSION; HEART TAMPONADE; HIGH RISK PATIENT; HOXA TLX1 GENE; HUMAN; IMMUNE DEFICIENCY; IMMUNOPHENOTYPING; INTESTINE INTUSSUSCEPTION; JAW TUMOR; LEUKEMIA; LIVER; LYMPH NODE; MAINTENANCE THERAPY; MALARIA; NAUSEA AND VOMITING; OVERALL SURVIVAL; PERICARDIAL EFFUSION; PLEOCYTOSIS; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; REVIEW; RISK MANAGEMENT; SKIN; SPLEEN; SUPERIOR CAVA VEIN OBSTRUCTION; SYSTEMIC THERAPY; T CELL LYMPHOMA; TESTIS; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR CELL DESTRUCTION; TUMOR LOCALIZATION;

BURKITT LYMPHOMA; EUROPE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; UNITED STATES;

EID: 54049151654     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2008.07.009     Document Type: Review

References (45)

1. The non-Hodgkin's Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphomas. Blood 89 (1997) 3909-3918
2. Jaffe E.S., Harris N.L., Stein H., et al. Tumors of the haematopoietic and lymphoid tissues. World Health Organization (2001), IARC Press, Lyon (France)
3. Raetz E.A., Perkins S.L., Bhojwani D., et al. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatr Blood Cancer 47 (2006) 130-140
4. Rosen P.J., Feinstein D.I., Pattengale P.K., et al. Convoluted lymphocytic lymphoma in adults: a clinicopathological entity. Ann Intern Med 89 (1978) 319-324
5. Nathwani B.N., Diamond L.W., Winberg C.D., et al. Lymphoblastic lymphoma: a clinicopathologic study of 95 patients. Cancer 48 (1978) 2347-2357
6. Sweetenham J.W., Santini G., Qian W., et al. High-dose therapy and autologous stem-cell transplantation versus conventional dose consolidation/maintenance therapy as post-remission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group. J Clin Oncol 19 (2001) 2927-2936
7. Coleman N.C., Picozzi V.J., Cox R.S., et al. Treatment of lymphoblastic lymphoma in adults. J Clin Oncol 4 (1986) 1626-1637
8. Slater D.E., Mertelsmann R., Koriner B., et al. Lymphoblastic lymphoma in adults. J Clin Oncol 4 (1986) 57-67
9. Bernasconi C., Brusamolino E., Lazzarino M., et al. Lymphoblastic lymphoma in adult patients; clinicopathological features and response to intensive multi-agent chemotherapy analogous to that used in acute lymphoblastic leukemia. Ann Oncol 1 (1990) 141-160
10. Morel P., Lepage E., Brice P., et al. Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients. J Clin Oncol 10 (1992) 1078-1085
11. Bouabdallah R., Xerri L., Bardou V.-J., et al. Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center. Ann Oncol 9 (1998) 619-625
12. Voakes J.B., Jones S.E., and McKelvey E.M. The chemotherapy of lymphoblastic lymphoma. Blood 57 (1981) 186-188
13. Czuczman M.S., Dodge R.K., Stewart C.C., et al. Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8364. Blood 93 (1999) 3931-3939
14. Xia Y., Brown L., Yang C.Y., et al. TAL2, a helix-loop-helix gene activated by the t(7;9)(q34;q32) translocation in human T-cell leukemia. Proc Natl Acad Sci USA 88 (1989) 11416-11420
15. Baleydier F., Decouvelaere A.-V., Bergeron J., et al. T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome. Clin Cancer Res 14 (2008) 692-700
16. Jost L.M., Jacky E., Dommann-Scherrer C., et al. Short-term weekly chemotherapy followed by high dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients. Ann Oncol 6 (1995) 445-451
17. LeGouill S., Lepretre S., Briere J., et al. Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87/93 trials. Leukemia 17 (2003) 2220-2224
18. van Imhoff G.W., van der Holt B., MacKenzie M.A., et al. Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. Leukemia 19 (2005) 945-952
19. 2). N Engl J Med 308 (1983) 559-565
20. Colgan J.P., Andersen J., Habermann T.M., et al. Long-term follow up of a XCHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma. Leuk Lymphoma 15 (1994) 291-296
21. Kaiser U., Uebelacker I., and Havemann K. Non-Hodgkin's lymphoma protocols in the treatment of patients with Burkitt's lymphoma and lymphoblastic lymphoma: a report on 58 patients. Leuk Lymphoma 36 (1999) 101-108
22. Hoelzer D., Gokbuget N., Digel W., et al. Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood 99 (2002) 4379-4385
23. Thomas D.A., O'Brien S., Cortes J., et al. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood 104 (2004) 1624-1630
24. Jabbour E., Koscielny S., Sebban C., et al. High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL). Leukemia 20 (2006) 814-819
25. Song K.W., Barnett M.J., Gascoyne R.D., et al. Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes. Ann Oncol 18 (2007) 535-540
26. Burkhardt B., Woessmann W., Zimmermann M., et al. Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. J Clin Oncol 24 (2006) 491-499
27. Dabaja B.S., Ha C.S., Thomas D.A., et al. The role of local radiation therapy for mediastinal disease for adults with T-cell lymphoblastic lymphoma. Cancer 94 (2002) 2738-2744
28. Sweetenham J.W., Santini G., Pearce R., et al. High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results from the European Group for Bone Marrow Transplantation. J Clin Oncol 12 (1994) 1358-1365
29. Peniket A.J., Ruiz de Elvira M.C., Taghipour G., et al. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transplant 8 (2003) 667-678
30. Levine J.E., Harris R.E., Loberiza F.R., et al. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood 101 (2003) 2476-2482
31. DeAngelo D.J., Yu D., Johnson J.L., et al. Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B Study 19801. Blood 109 (2007) 5136-5142
32. Dace S., Fu K., Wright G.W., et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 354 (2006) 2431-2442
33. Hummel M., Bentinck S., Berger H., et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 354 (2006) 2419-2430
34. Magrath I.M., Shad A., et al. Children and adults with small non-cleaved cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 14 (1996) 925-934
35. Mead G.M., Sydes M.R., Walewski J., et al. An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol 13 (2002) 1264-1274
36. Reiter A., Schrappe M., Tiemann M., et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munich NHL-BFM 90. Blood 94 (1999) 3294-3306
37. Patte C., Michon J., Frappaz D., et al. Therapy of Burkitt and other B-cell acute lymphoblastic leukemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults. Baillieres Clin Haematol 2 (1994) 339-348
38. Soussain C., Patte C., Ostronoff M., et al. Small non-cleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 85 (1995) 664-674
39. McMaster M., Greer J.P., Greco A., et al. Effective treatment of small-noncleaved cell lymphoma with high-intensity, brief duration chemotherapy. J Clin Oncol 9 (1991) 941-946
40. Thomas D.A., Cortes J., O'Brien S., et al. Hyper-CVAD program in Burkitt's type adult acute lymphoblastic leukemia. J Clin Oncol 17 (1999) 2461-2470
41. Thomas D.A., Faderl S., O'Brien S., et al. Chemoimmunotherapy with Hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer 106 (2006) 1569-1580
42. Rizzieri D.A., Johnson J.L., Niedzwiecki D., et al. Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma. Cancer 100 (2004) 1438-1448
43. Sweetenham J.W., Pearce R., Taghipour G., et al. Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma-outcome for patients treated with high-dose therapy and autologous stem cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantation. J Clin Oncol 14 (1996) 2465-2472
44. Song K.W., Barnett M.J., Gascoyne R.D., et al. Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma. Br J Haematol 133 (2006) 634-637
45. Chopra R., Goldstone A.H., Pearce R., et al. Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case controlled analysis of the European Bone Marrow Transplant Group registry data. J Clin Oncol 10 (1992) 1690-1695